Background: Neuroinvasive properties of SARS-CoV-2 have allowed the hypothesis of
several pathogenic mechanisms related to acute and chronic neurological sequelae …

Cannabidiol (CBD) is one of the prominent phytocannabinoids found in Cannabis sativa,
differentiating from Δ9-tetrahydrocannabinol (THC) for its non-intoxicating profile and its …

Objective Valproate (VPA) use in women with idiopathic generalized epilepsy (IGE) who are
of reproductive age has been a matter of concern and debate, which eventually led to the …

Background In randomized controlled trials, add-on brivaracetam (BRV) reduced seizure
frequency in patients with drug-resistant focal epilepsy. Studies performed in a naturalistic …

Objective To assess prognostic patterns and investigate clinical and
electroencephalography (EEG) variables associated with persistent treatment resistance in …

Purpose Seizures are common in autoimmune encephalitis (AE), and an extensive work-up
is required to exclude alternative etiologies. The aim of our study was to identify possible …

Objective To investigate the electroclinical characteristics and the prognostic impact of
generalized fast discharges in a large cohort of genetic generalized epilepsy (GGE) patients …

Rufinamide (RFD) is a novel drug that was recently approved as an adjunctive treatment for
Lennox-Gastaut syndrome. Despite its reported effectiveness in generalized seizures (tonic …

Perampanel (PER) is a novel anti-seizure medication useful in different types of epilepsy.
We intended to assess the effectiveness of PER on cortical myoclonus and seizure …

Introduction In randomized controlled trials, add-on brivaracetam (BRV) reduced seizure
frequency in patients with drug-resistant focal epilepsy. Most real-world research on BRV …